Vivacy - photo of woman smiling

Vivacy

Sector Healthcare
Location Paris
Date acquired 2023
Transaction size Not disclosed

A leading developer of dermal fillers and other medical devices


The investment in Vivacy was made by Bridgepoint Europe. 

To learn more about the company, click here.

Laboratoires Vivacy (Vivacy) has pioneered hyaluronic acid-based, injectable products used in non-invasive medical aesthetics procedures.

Founded in 2007, the business maintains a strong presence in Europe and exports to more than 85 countries worldwide.

Alongside its flagship Stylage line, Vivacy continues to innovate and expand its offering, which includes premium skincare products and medical devices used in applications such as rheumatology and ophthalmology.

Vivacy benefits from a sizeable, high-growth end market, characterised by high barriers to entry as well as strong structural appeal for high-quality, safe wellness and anti-ageing treatments and procedures among a growing addressable population. Vivacy’s products enjoy strong brand recognition among healthcare professionals for their quality and ease of use.

We use strictly necessary cookies to make our site work. Currently the analytics cookies which allow us to collect information about how visitors use our website and help us to improve it; is defaulted to ‘InActive’, if you wish to turn this on you can do so through the Cookie Settings. Please be aware that by blocking some types of cookies it may impact your experience of the site and the services we are able to offer. For more information about any of these cookies and our use of them, or to change your settings at any time, please see Cookie Settings and Cookies Policy.